Tasuku Honjo

USPTO Granted Patents = 5

Forward Citations = 252

Loading Chart...

13 inventors (with patents filed for the assignee):

Tasuku Honjo (5 out of 40 patents)

Shiro Shibayama (2 out of 52 patents)

Takao Yoshida (1 out of 13 patents)

4. Takashi Shinohara (1 out of 12 patents)

5. Kazuhiko Takeda (1 out of 8 patents)

6. Nagahiro Minato (1 out of 14 patents)

7. Masakazu Miyamoto (1 out of 9 patents)

8. Hideaki Tada (1 out of 17 patents)

9. Masayoshi Matsuo (1 out of 8 patents)

10. Yoshiko Iwai (1 out of 8 patents)

11. Akira Shimizu (1 out of 7 patents)

12. Kei Tashiro (1 out of 11 patents)

13. Yasumasa Ishida (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 9393301 - Immunopotentiative composition (2016-07-19),

2. 8246955 - Substance specific to human PD-1 (2012-08-21),

3. 5629204 - Peptide related to human programmed cell death and DNA encoding it (1997-05-13),

4. 5525486 - Process for constructing cDNA library, and novel polypeptide and DNA (1996-06-11),

5. 4816565 - Interleukin 2 receptor and a method for production thereof (1989-03-28),

Tasuku Honjo is a Japanese immunologist who won the Nobel Prize in Physiology or Medicine in 2018 for his discovery of cancer therapy by inhibition of negative immune regulation. He is a professor in the Department of Immunology and Genomic Medicine at Kyoto University. His research focuses on understanding the mechanisms of immune regulation and applying that knowledge to develop new cancer immunotherapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#314 in

#6,487 in Japan

JP